|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$2.12 |
$2.14 |
$1.93 |
$1.96 |
250.50K | 04/22/2024 |
$1.91 |
$1.94 |
$1.70 |
$1.82 |
144.00K | 04/23/2024 |
$1.82 |
$1.96 |
$1.82 |
$1.85 |
54.90K | 04/24/2024 |
$1.83 |
$1.94 |
$1.83 |
$1.89 |
65.80K | 04/25/2024 |
$1.88 |
$1.97 |
$1.76 |
$1.79 |
128.60K |
|
TRACON Pharmaceuticals is a biopharmaceutical company. Co. has a collaboration and clinical trial agreement for the development of envafolimab, an investigational PD-L1 single-domain antibody for the treatment of sarcoma in North America. Co.'s other clinical stage oncology product candidates include YH001, which is a monospecific investigational cytotoxic T-lymphocyte-associated protein 4 antibody, TRC102, which is a small molecule that has been studied in Phase 1 and Phase 2 trials for the treatment of mesothelioma, lung cancer, glioblastoma and solid tumors, and TJ004309, which is a CD73 antibody in Phase 1 clinical development for the treatment of solid tumors. | |
|
TRACON Pharmaceuticals (TCON) has the following price history information. Looking back at TCON historical stock prices for the last five trading days, on April 19, 2024, TCON opened at $2.12, traded as high as $2.14 and as low as $1.93, and closed at $1.96. Trading volume was a total of 250.50K shares. On April 22, 2024, TCON opened at $1.91, traded as high as $1.94 and as low as $1.70, and closed at $1.82. Trading volume was a total of 144.00K shares. On April 23, 2024, TCON opened at $1.82, traded as high as $1.96 and as low as $1.82, and closed at $1.85. Trading volume was a total of 54.90K shares. On April 24, 2024, TCON opened at $1.83, traded as high as $1.94 and as low as $1.83, and closed at $1.89. Trading volume was a total of 65.80K shares. On April 25, 2024, TCON opened at $1.88, traded as high as $1.97 and as low as $1.76, and closed at $1.79. Trading volume was a total of 128.60K shares.
TCON Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into TRACON Pharmaceuticals shares, starting with a $10,000 purchase of TCON, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/02/2015 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$1,900.00 |
|
End price/share: |
$1.79 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.91% |
|
Average Annual Total Return: |
-52.99% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$9.42 |
|
Years: |
9.23 |
|
|
|
Date |
Close |
04/19/2024 | $1.96 | 04/22/2024 | $1.82 | 04/23/2024 | $1.85 | 04/24/2024 | $1.89 | 04/25/2024 | $1.79 |
|
|